Antiviral drugs Market Size, Share, Trends and Forecast (2035)
The Antiviral Drugs Market is estimated to grow at a CAGR of 6.3% during the period 2022–2035, claims Roots Analysis. Over the years, there has been a growing focus on the development of safe and effective novel antiviral drugs therapeutics owing to the rising cases of life-threatening viral diseases
The study features an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Amongst other elements, the report features:
- A detailed assessment of the current market landscape of commercially available antiviral drugs.
- A detailed assessment of the current market landscape of clinical-stage antiviral drugs.
- An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2019–2022 (till May).
- A detailed analysis of investments that have been made into companies engaged in the antiviral drugs domain, during the period 2019–2022 (till May).
- A qualitative analysis of the five competitive forces under an insightful Porter’s Five Forces framework.
- Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in development of antiviral drugs.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
Mechanism of Action
- Fusion Inhibitors
- DNA Polymerases
- Protease Inhibitors
- Reverse Transcriptase Inhibitors
- Other Mechanisms
- Target Indication
- Human Immunodeficiency Virus Infection
- Hepatitis
- Herpes Simplex Virus Infection
- Cytomegalovirus Infection\
- Influenza
- Coronavirus Infection
- Other Target Indications
Type of Drug Target
- Virus Targets
- Host Targets
Type of Therapy
- Monotherapy
- Combination Therapy
Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- MENA
- Rest of the World
Key companies covered in the report
- AbbVie
- AstraZeneca
- Bristol-Myers Squibb
- Genentech
- Gilead Sciences
- GlaxoSmithKline (GSK)
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- ViiV Healthcare
For additional details, please visit https://www.rootsanalysis.com/reports/antiviral-drugs-market.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
